Viracept (Nelfinavir)
| Brand Name: |
Viracept |
| Generic Name: |
Nelfinavir, NFV |
| Adult Single Dose: |
Two 625-mg tablets or five 250-mg tablets (twice a day) OR three 250-mg tablets three times a day |
| Food & Liquid Restrictions: |
Take with a meal |
| Drug Class: |
PI |
The Basics
- An Overview of Viracept (Nelfinavir) (September 13, 2012)
From AIDSinfo
- Viracept (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Nelfinavir (Viracept) (February 9, 2012)
To read PDF, click here.
From AIDS InfoNet
- Patient Information About Viracept (Nelfinavir) (PDF) (February 2011)
From ViiV Healthcare
- Viracept (Nelfinavir) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Nelfinavir (Viracept) (August 15, 2006)
From AIDS Treatment Data Network
- Viracept (Nelfinavir) (May 2005)
To read PDF, click here.
From The Center for AIDS
- Drug Interactions: Nelfinavir (August 2004)
From Project Inform
- Bon Appetite -- Using Food to Boost Your Viracept (July/August 2003)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Why It's Important to Eat When Taking Viracept (August/September 2002)
In Reasons for Hope, from Search for a Cure
News
- Roche to Discontinue Production of Nelfinavir and Saquinavir 200-mg Hard Capsules (September/October 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Nelfinavir Interaction With Warfarin (March/April 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Viracept (Nelfinavir) Label Change Reflects Drug-Drug Interaction Information With Warfarin (February 24, 2011)
From U.S. Food and Drug Administration
- Viracept (Nelfinavir Mesylate) 250 mg, 625 mg Tablets, and Powder for Oral Suspension: Important Information for Prescribers (PDF) (May 6, 2008)
From Pfizer, Inc.
- Heavy Restrictions on Nelfinavir Use Recommended for Pediatric Patients, Pregnant Women in United States (September 10, 2007)
From U.S. Food and Drug Administration
- European Union Suspends Roche HIV Drug Due to Toxic Contamination (August 7, 2007)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Roche Admits Long-Standing, Low-Level Contamination of Nelfinavir (July 26, 2007)
New information reveals contamination dating back to the drug's release in 1998; United States, Canada and Japan are the only unaffected countries.
From aidsmap.com
- Viracept Recall Creates Panic in Zambia (June 19, 2007)
From United Nations Integrated Regional Information Networks
- European Medicines Agency Recalls Roche Antiretroviral Viracept Because of Contamination (June 8, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- New Nelfinavir Formulation Now Available for Patients With HIV (June 1, 2004)
A Pfizer press release on nelfinavir's new twice-a-day dosing option.
From Pfizer, Inc.
VIEW ALL ARTICLES
|
|
Advertisement
|
Email
Glossary
